Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer

NCT ID: NCT01216813

Last Updated: 2016-11-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

33 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-08-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

RATIONALE: Gathering information from patients who have undergone treatment for upper gastrointestinal cancer or gynecological cancer may help doctors learn more about patients' physical and psychosocial rehabilitation needs and plan the best treatment.

PURPOSE: This clinical trial is studying the physical and psychosocial rehabilitation needs of patients after diagnosis and treatment of upper gastrointestinal cancer or gynecological cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

OBJECTIVES:

Primary

* To explore the patients' perspective of their physical and psychosocial rehabilitation needs following the diagnosis and treatment for an upper gastrointestinal or a gynecological cancer.
* To assess patients' experiences of the physical and social impact of cancer in the treatment and post-treatment phase.
* To explore patients' met and un-met needs.
* To explore the patients' opinion of how it might be possible to manage any of the issues that arise.

Secondary

* To generate theories and a hypothesis from the data collected for use in a future interventional study.

OUTLINE: The study consist of a series of focus groups that take place in a private room within the Royal Marsden Hospital in the United Kingdom. Patients attend only one focus group session, which is audio-tape recorded. The focus groups discuss and explore the patient's needs and experiences using a semi-structured interview question schedule over 60-90 minutes. The groups are single-sex groups to allow the patients to express themselves freely with respect to any sensitive topics they may wish to discuss. If individual patient issues arise from the group discussions, the lead researcher may refer the patient to a member of the hospital team, the patient's physician, or for appropriate psychological support.

Data from the focus group dialogue and patients' baseline demographic information are analyzed. The results from this study are used to design an interventional study in the Rehabilitation Department.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adenocarcinoma of the Gastroesophageal Junction Cervical Cancer Endometrial Cancer Esophageal Cancer Fallopian Tube Cancer Gastric Cancer Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

esophageal cancer gastric cancer cervical cancer fallopian tube cancer ovarian epithelial cancer ovarian germ cell tumor ovarian sarcoma ovarian stromal cancer endometrial cancer uterine sarcoma vaginal cancer vulvar cancer adenocarcinoma of the gastroesophageal junction

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

informational intervention

Intervention Type OTHER

assessment of therapy complications

Intervention Type PROCEDURE

psychosocial assessment and care

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

PRIOR CONCURRENT THERAPY:

* See Disease Characteristics
Minimum Eligible Age

18 Years

Maximum Eligible Age

120 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Royal Marsden NHS Foundation Trust

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clare Shaw, Phd

Role: PRINCIPAL_INVESTIGATOR

Royal Marsden NHS Foundation Trust

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Royal Marsden - London

London, England, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RMNHS-REHABILITATION

Identifier Type: -

Identifier Source: secondary_id

EU-21074

Identifier Type: -

Identifier Source: secondary_id

RMNHS-CCR3434

Identifier Type: -

Identifier Source: secondary_id

MREC-10/H0806/56

Identifier Type: -

Identifier Source: secondary_id

CDR0000686456

Identifier Type: -

Identifier Source: org_study_id